We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > glaucoma

News List

Aerie Pharmaceuticals Expands Commercialization Team americanpharmaceuticalreview
April 12, 2017
Aerie Pharmaceuticals, a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye
Santen and twoXAR to identify new drug candidates for glaucoma pharmaceutical-technology
February 28, 2017
US-based ophthalmology company Santen and biopharmaceutical company twoXAR have entered a strategic research collaboration to identify new drug candidates for glaucoma.
Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments americanpharmaceuticalreview
February 24, 2017
Santen, Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., the specialty ophthalmology company headquartered in Osaka, Japan, and twoXAR, Inc., an artificial intelligence-driven biopharmaceutical company, announced that the two companies have e

Previous page 1 2 3 Next page